Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.38 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.38 |
| ▸ | TAS1R2 | Q8TE23 | 3/20 | 0.38 |
| ▸ | VDR | P11473 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11053483 | 0.83 | MEN1 (0.51) | L3MBTL1KDM4EALDH1A1MAPTMAPK1 | |
| SCHEMBL6907962 | 0.83 | MEN1 (0.43) | L3MBTL1KDM4EALDH1A1MAPTMAPK1 | |
| SCHEMBL18535093 | 0.81 | L3MBTL1 (0.43) | L3MBTL1KDM4EALDH1A1MAPTMAPK1 | |
| SCHEMBL4320007 | 0.78 | ALDH1A1 (0.45) | L3MBTL1KDM4EALDH1A1MAPTMAPK1 | |
| Phosphine SCHEMBL28030392 | 0.73 | ALDH1A1 (0.41) | L3MBTL1KDM4EALDH1A1MAPTMAPK1 | |
| SCHEMBL6908084 | 0.73 | MEN1 (0.44) | L3MBTL1KDM4EALDH1A1MAPTMAPK1 | |
| SCHEMBL6905835 | 0.73 | ALDH1A1 (0.41) | L3MBTL1KDM4EALDH1A1MAPTMAPK1 | |
| SCHEMBL8412772 | 0.73 | ALDH1A1 (0.47) | L3MBTL1KDM4EALDH1A1MAPTMAPK1 | |
| SCHEMBL13543176 | 0.73 | KDM4E (0.46) | L3MBTL1KDM4EALDH1A1MAPTMAPK1 | |
| SCHEMBL11210247 | 0.73 | MEN1 (0.50) | L3MBTL1KDM4EALDH1A1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2477739-B1 | PHOTO-LATENT TITANIUM CATALYSTS | BASF SE (DE) | 2019-04-10 | — | — | EP | disclosed |
| US-10207261-B2 | Photo-latent titanium catalysts | BASF SE (DE) | 2019-02-19 | — | — | US | disclosed |
| US-10167303-B2 | Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex | UDC IRELAND LIMITED (IE) | 2019-01-01 | — | — | US | disclosed |
| US-20180090693-A1 | TRANSITION METAL COMPLEXES WITH CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | UDC IRELAND LTD (IE) | 2018-03-29 | — | — | US | disclosed |
| US-20180090693-A1 | TRANSITION METAL COMPLEXES WITH CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | UDC IRELAND LTD (IE) | 2018-03-29 | — | — | US | disclosed |
| EP-2991997-B1 | TRANSITION METAL COMPLEXES WITH CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | UDC IRELAND LTD (IE) | 2018-02-21 | — | — | EP | disclosed |
| EP-2802594-B1 | METAL COMPLEXES WITH DIBENZO[F,H]QUINOXALINES | UDC IRELAND LTD (IE) | 2017-04-19 | — | — | EP | disclosed |
| US-9590196-B2 | Dinuclear metal complexes comprising carbene ligands and the use thereof in OLEDs | UDC IRELAND LIMITED (IE) | 2017-03-07 | — | — | US | disclosed |
| US-9590196-B2 | Dinuclear metal complexes comprising carbene ligands and the use thereof in OLEDs | UDC IRELAND LIMITED (IE) | 2017-03-07 | — | — | US | disclosed |
| US-20170044194-A1 | Metal Complexes with Dibenzo[f,h]quinoxalines | UDC IRELAND LTD (IE) | 2017-02-16 | — | — | US | disclosed |
| US-20150243912-A1 | TRANSITION METAL COMPLEXES WITH CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2015-08-27 | — | — | US | disclosed |
| US-20150171350-A1 | DINUCLEAR METAL COMPLEXES COMPRISING CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | UDC IRELAND LIMITED (IE) | 2015-06-18 | — | — | US | disclosed |
| US-20150171350-A1 | DINUCLEAR METAL COMPLEXES COMPRISING CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | UDC IRELAND LIMITED (IE) | 2015-06-18 | — | — | US | disclosed |
| US-20150005497-A1 | METAL COMPLEXES WITH DIBENZO[F,H]QUINOXALINES | BASF SE (DE) | 2015-01-01 | — | — | US | disclosed |
| US-20150005497-A1 | METAL COMPLEXES WITH DIBENZO[F,H]QUINOXALINES | BASF SE (DE) | 2015-01-01 | — | — | US | disclosed |
| WO-2014177518-A1 | TRANSITION METAL COMPLEXES WITH CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2014-11-06 | — | — | WO | disclosed |
| WO-2013104649-A1 | METAL COMPLEXES WITH DIBENZO[F,H]QUINOXALINES | BASF SE (DE) | 2013-07-18 | — | — | WO | disclosed |
| US-20120220685-A1 | PHOTO-LATENT TITANIUM CATALYSTS | BASF SE (DE) | 2012-08-30 | — | — | US | disclosed |
| EP-2477739-A1 | PHOTO-LATENT TITANIUM CATALYSTS | BASF SE (DE) | 2012-07-25 | — | — | EP | disclosed |
| WO-2011032875-A1 | PHOTO-LATENT TITANIUM CATALYSTS | BASF SE (DE) | 2011-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10167303-B2 | Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex | NDUFS5, DDT, NDUFV2 | L3MBTL1 1863/4885KDM4E 1275/4885ALDH1A1 367/4885 |
| US-20170044194-A1 | Metal Complexes with Dibenzo[f,h]quinoxalines | NDUFS2, OCIAD2, NDUFS3 | L3MBTL1 2458/4885KDM4E 3445/4885ALDH1A1 1199/4885 |
| US-20180090693-A1 | TRANSITION METAL COMPLEXES WITH CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | OCIAD2, OCIAD1, TRPM6 | L3MBTL1 3463/4885KDM4E 4841/4885ALDH1A1 2141/4885 |
| US-20150243912-A1 | TRANSITION METAL COMPLEXES WITH CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | OCIAD1, OCIAD2, OXA1L | L3MBTL1 3213/4885KDM4E 4844/4885ALDH1A1 1439/4885 |
| US-20150171350-A1 | DINUCLEAR METAL COMPLEXES COMPRISING CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | OCIAD1, OCIAD2, PDCD6 | L3MBTL1 3068/4885KDM4E 4799/4885ALDH1A1 2810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.